Researchers in the Department of Dermatology are seeking participants age 2-17 with eczema for a research study. This study is investigating whether crisaborole (Eucrisa) can reduce topical steroid usage. Participation in this study involves use of Eucrisa, a safe, FDA-approved, and commonly used medication in the management of eczema. This study also involves surveys, skin exams, and photographs.
Participants will make three visits to the Johns Hopkins Dermatology Department and receive a total compensation of $400.
If you are interested in this study, email email@example.com or call 410-502-7546.